Tandem Diabetes Care, Inc. TNDM
Free
No email, no account, no signup.
General analysis — not personal advice.
Bull
Bear
Want to follow Tandem Diabetes Care, Inc.? Create a free account — 3 companies, change history, weekly brief, and email when the picture changes.
Follow 3 companies freeEmail when the signal or risk changes · Sunday weekly brief
No card · No time limit on free tier · Upgrade when you need more
Exchange
NASDAQ
Type
Technology
Sector
Diabetes care medical technology
Price & valuation
Last close
USD 23.44
1 week
+24.7 %
3 months
+65.7 %
12 months
+110.6 %
From 52w high
-17.1 %
From 52w low
+131.7 %
We're already tracking Tandem Diabetes Care, Inc. — here are the latest events we've registered
Recent News
- On June 5, 2026, the company announced it received CE Mark clearance in Europe for expanded indications of its automated insulin delivery systems. The approval allows the use of its t:slim X2 and Tandem Mobi systems for adults with type 2 diabetes and pregnant women with type 1 diabetes.
What Firelda Watch includes for Tandem Diabetes Care, Inc.
Add the company to your watchlist and get all of this automatically.
- Free: 3 companies on your watchlist
- Change history and monitoring for every company you follow
- Sunday weekly brief — AI roundup of the week's news
- Watch/Ultra: same-day email when something material happens
Want to see what a finished analysis looks like?
View a sample analysis
This is a real Firelda analysis. Your analysis of Tandem Diabetes Care, Inc. will be delivered in the same format.
Want to follow Tandem Diabetes Care, Inc.? Create a free account — 3 companies, change history, weekly brief, and email when the picture changes.
Follow 3 companies freeEmail when the signal or risk changes · Sunday weekly brief
No card · No time limit on free tier · Upgrade when you need more
Firelda provides general information and analysis, not personal investment advice. Content does not consider your financial situation or goals. Investments can rise and fall in value. Always do your own research.